HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells.

AbstractPURPOSE:
To examine the effect of several agents that either stimulate or inhibit neovascularization on plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells and vascular endothelial cells.
METHODS:
Steady-state levels of messenger RNA were assessed by Northern blots and dot blots and protein levels were assessed by immunoprecipitation.
RESULTS:
Data indicate that messenger RNA levels for plasminogen activator inhibitor-1 are modulated in similar fashion in both cells types, being increased by incubation with transforming growth factor-beta, dexamethasone, tumor necrosis factor, phorbol myristate acetate, and thrombin. Levels of urokinase messenger RNA in retinal pigmented epithelial cells are significantly increased only by phorbol myristate acetate and are decreased by dexamethasone and transforming growth factor-beta, whereas in endothelial cells plasminogen activator urokinase messenger RNA is increased by each of the stimuli except dexamethasone, which causes a decrease. Immunoprecipitation experiments demonstrate similar modulation of inhibitor-1 proteins secreted by retinal pigmented epithelial cells, whereas urokinase is difficult to detect.
CONCLUSIONS:
These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization.
AuthorsS F Hackett, P A Campochiaro
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 34 Issue 6 Pg. 2055-61 (May 1993) ISSN: 0146-0404 [Print] United States
PMID8491554 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Biological Factors
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • Dexamethasone
  • Thrombin
  • Urokinase-Type Plasminogen Activator
  • Tetradecanoylphorbol Acetate
Topics
  • Aged
  • Biological Factors (pharmacology)
  • Blotting, Northern
  • Cells, Cultured
  • Dexamethasone (pharmacology)
  • Electrophoresis, Agar Gel
  • Endothelium, Vascular (drug effects, metabolism)
  • Humans
  • Infant
  • Middle Aged
  • Pigment Epithelium of Eye (drug effects, metabolism)
  • Plasminogen Activator Inhibitor 1 (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • Tetradecanoylphorbol Acetate (pharmacology)
  • Thrombin (pharmacology)
  • Urokinase-Type Plasminogen Activator (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: